{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:02:27Z","timestamp":1782316947111,"version":"3.54.5"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"FAPERJ JCE","award":["212485"],"award-info":[{"award-number":["212485"]}]},{"name":"CNPQ Universal","award":["486580\/2013-0"],"award-info":[{"award-number":["486580\/2013-0"]}]},{"name":"FAPERJ APQ1","award":["207296"],"award-info":[{"award-number":["207296"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13071-016-1822-9","type":"journal-article","created":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T10:33:58Z","timestamp":1475750038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl\/6 mice"],"prefix":"10.1186","volume":"9","author":[{"given":"Juliana Elena Silveira","family":"Pratti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeu Diniz","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce Carvalho","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Marcia","family":"da Fonseca-Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo","family":"Maciel-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Oliveira-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian Fran\u00e7a","family":"de Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana Passos","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Claudio Oliveira","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Louren\u00e7o","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartira","family":"Rossi-Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert Leonel","family":"de Matos Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,6]]},"reference":[{"issue":"5","key":"1822_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, V\u00e9lez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M. WHO Leishmaniasis Control Team. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5), e35671. doi: 10.1371\/journal.pone.0035671 .","journal-title":"PLoS One"},{"issue":"8","key":"1822_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1365-3024.2009.01116.x","volume":"31","author":"FT Silveira","year":"2009","unstructured":"Silveira FT, Lainson R, De Castro Gomes CM, Laurenti MD, Corbett CE. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis. Parasite Immunol. 2009;31(8):423\u201331. doi: 10.1111\/j.1365-3024.2009.01116.x .","journal-title":"Parasite Immunol"},{"key":"1822_CR3","unstructured":"Manual de vigil\u00eancia de Leishmaniose Tegumentar Americana\/Minist\u00e9rio da Sa\u00fade, Secretaria de Vigil\u00e2ncia em Sa\u00fade, Departamento de vigil\u00e2ncia Epidemiol\u00f3gica. S\u00e9rie A. Normas e Manuais T\u00e9cnicos. -2 ed. Bras\u00edlia: Editora do Minist\u00e9rio da Sa\u00fade; 2007. p. 182. http:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/manual_vigilancia_leishmaniose_2ed.pdf ."},{"issue":"3","key":"1822_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00436-010-2139-9","volume":"108","author":"LI Camara Coelho","year":"2011","unstructured":"Camara Coelho LI, Paes M, Guerra JA, Barbosa M, Coelho C, Lima B, et al. Characterization of Leishmania spp. causing cutaneous leishmaniasis in Manaus, Amazonas, Brazil. Parasitol Res. 2011;108(3):671\u20137. doi: 10.1007\/s00436-010-2139-9 .","journal-title":"Parasitol Res"},{"issue":"5","key":"1822_CR5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4269\/ajtmh.1991.44.536","volume":"44","author":"A Barral","year":"1991","unstructured":"Barral A, Pedral-Sampaio D, Grimaldi J\u00fanior G, Momen H, McMahon-Pratt D, Ribeiro de Jesus A, et al. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg. 1991;44(5):536\u201346.","journal-title":"Am J Trop Med Hyg"},{"key":"1822_CR6","doi-asserted-by":"publisher","unstructured":"de Menezes JP, Guedes CE, Petersen AL, Fraga DB, Veras PS. Advances in development of new treatment for leishmaniasis. Biomed Res Int. 2015;815023. doi: 10.1155\/2015\/815023","DOI":"10.1155\/2015\/815023"},{"issue":"4","key":"1822_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.vetpar.2008.09.015","volume":"158","author":"BA Pereira","year":"2008","unstructured":"Pereira BA, Alves CR. Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis. Vet Parasitol. 2008;158(4):239\u201355. doi: 10.1016\/j.vetpar.2008.09.015 . Epub 2008 Sep 18.","journal-title":"Vet Parasitol"},{"issue":"7","key":"1822_CR8","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1128\/IAI.61.7.2952-2959.1993","volume":"61","author":"LC Afonso","year":"1993","unstructured":"Afonso LC, Scott P. Immune responses associated with susceptibility of C57BL\/10 mice to Leishmania amazonensis. Infect Immun. 1993;61(7):2952\u20139.","journal-title":"Infect Immun"},{"issue":"8","key":"1822_CR9","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1128\/IAI.71.8.4278-4288.2003","volume":"71","author":"J Ji","year":"2003","unstructured":"Ji J, Sun J, Soong L. Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect Immun. 2003;71(8):4278\u201388.","journal-title":"Infect Immun"},{"issue":"4","key":"1822_CR10","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/IAI.70.4.2151-2158.2002","volume":"70","author":"DE Jones","year":"2002","unstructured":"Jones DE, Ackermann MR, Wille U, Hunter CA, Scott P. Early enhanced Th1 response after Leishmania amazonensis infection of C57BL\/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect Immun. 2002;70(4):2151\u20138.","journal-title":"Infect Immun"},{"issue":"5","key":"1822_CR11","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.4049\/jimmunol.174.5.2934","volume":"174","author":"CF Anderson","year":"2005","unstructured":"Anderson CF, Mendez S, Sacks DL. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL\/6 mice. J Immunol. 2005;174(5):2934\u201341.","journal-title":"J Immunol"},{"issue":"9","key":"1822_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003889","volume":"9","author":"ER Mears","year":"2015","unstructured":"Mears ER, Modabber F, Don R, Johnson GE. A review: The current in vivo models for the discovery and utility of new anti-leishmanial drugs targeting cutaneous leishmaniasis. PLoS Negl Trop Dis. 2015;9(9), e0003889. doi: 10.1371\/journal.pntd.0003889 .","journal-title":"PLoS Negl Trop Dis"},{"key":"1822_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/pim.12279","author":"ME Moura Lopes de","year":"2015","unstructured":"de Moura Lopes ME, Carneiro MB, Santos LM, Vieira LQ. Indigenous microbiota and leishmaniasis. Parasite Immunol. 2015. doi: 10.1111\/pim.12279 .","journal-title":"Parasite Immunol"},{"issue":"4","key":"1822_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.chom.2008.09.009","volume":"4","author":"II Ivanov","year":"2008","unstructured":"Ivanov II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 2008;4(4):337\u201349. doi: 10.1016\/j.chom.2008.09.009 .","journal-title":"Cell Host Microbe"},{"key":"1822_CR15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1186\/s13071-015-1246-y","volume":"8","author":"G Dom\u00ednguez-Bernal","year":"2015","unstructured":"Dom\u00ednguez-Bernal G, Horcajo P, Orden JA, Ruiz-Santa-Quiteria JA, De La Fuente R, Ord\u00f3\u00f1ez-Guti\u00e9rrez L, Mart\u00ednez-Rodrigo A, Mas A, Carri\u00f3n J. HisAK70: progress towards a vaccine against different forms of leishmaniosis. Parasit Vectors. 2015;8:629.","journal-title":"Parasit Vectors."},{"issue":"31 Suppl 2","key":"1822_CR16","doi-asserted-by":"crossref","first-page":"B244","DOI":"10.1016\/j.vaccine.2012.11.080","volume":"18","author":"J Alvar","year":"2013","unstructured":"Alvar J, Croft SL, Kaye P, Khamesipour A, Sundar S, Reed SG. Case study for a vaccine against leishmaniasis. Vaccine. 2013;18(31 Suppl 2):B244\u20139.","journal-title":"Vaccine"},{"issue":"9-10","key":"1822_CR17","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0264-410X(98)00338-7","volume":"17","author":"PM Luca De","year":"1999","unstructured":"De Luca PM, Mayrink W, Coutinho SG, Oliveira MP, Bertho AL, Toledo VP, et al. Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine agaisnt American tegumentar leishmaniasis. Vaccine. 1999;17(9-10):1179\u201385.","journal-title":"Vaccine"},{"key":"1822_CR18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.trstmh.2005.04.002","volume":"99","author":"ID Velez","year":"2005","unstructured":"Velez ID, Gilchrist K, Arbelaez MP, Rojas CA, Puerta JA, Antunes CM, et al. Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia. Trans R Soc Trop Med Hyg. 2005;99:593\u20138.","journal-title":"Trans R Soc Trop Med Hyg."},{"issue":"8","key":"1822_CR19","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.4049\/jimmunol.163.8.4481","volume":"163","author":"RT Kenney","year":"1999","unstructured":"Kenney RT, Sacks DL, Sypek JP, Vilela L, Gam AA, Evans-Davis K. Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis. J Immunol. 1999;163(8):4481\u20138.","journal-title":"J Immunol"},{"issue":"13","key":"1822_CR20","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.micinf.2005.04.016","volume":"7","author":"RO Pinheiro","year":"2005","unstructured":"Pinheiro RO, Pinto EF, Lopes JR, Guedes HL, Fentanes RF, Rossi-Bergmann B. TGF-beta-associated enhanced susceptibility to leishmaniasis following intramuscular vaccination of mice with Leishmania amazonensis antigens. Microbes Infect. 2005;7(13):1317\u201323.","journal-title":"Microbes Infect"},{"issue":"8","key":"1822_CR21","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1128\/IAI.72.8.4521-4527.2004","volume":"72","author":"EF Pinto","year":"2004","unstructured":"Pinto EF, Pinheiro RO, Rayol A, Larraga V, Rossi-Bergmann B. Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK. Infect Immun. 2004;72(8):4521\u20137.","journal-title":"Infect Immun"},{"key":"1822_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-bioeng-071811-150054","volume":"14","author":"KA Woodrow","year":"2012","unstructured":"Woodrow KA, Bennett KM, Lo DD. Mucosal vaccine design and delivery. Annu Rev Biomed Eng. 2012;14:17\u201346. doi: 10.1146\/annurev-bioeng-071811-150054 .","journal-title":"Annu Rev Biomed Eng."},{"issue":"13","key":"1822_CR23","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1017\/S0031182015001250","volume":"142","author":"JM Leal","year":"2015","unstructured":"Leal JM, Mosquini M, Covre LP, Stagmiller NP, Rodrigues RR, Christensen D, et al. Intranasal vaccination with killed Leishmania amazonensis promastigotes antigen (LaAg) associated with CAF01 adjuvant induces partial protection in BALB\/c mice challenged with Leishmania (infantum) chagasi. Parasitology. 2015;142(13):1640\u20136.","journal-title":"Parasitology"},{"key":"1822_CR24","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/1756-3305-7-448","volume":"7","author":"HL Matos Guedes de","year":"2014","unstructured":"de Matos Guedes HL, da Silva Costa BL, Chaves SP, de Oliveira Gomes DC, Nosanchuk JD, De Simone SG, Rossi-Bergmann B. Intranasal vaccination with extracellular serine proteases of Leishmania amazonensis confers protective immunity to BALB\/c mice against infection. Parasit Vectors. 2014;7:448. doi: 10.1186\/1756-3305-7-448 .","journal-title":"Parasit Vectors."},{"issue":"12","key":"1822_CR25","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1017\/S0031182012000868","volume":"139","author":"DC Oliveira Gomes De","year":"2012","unstructured":"De Oliveira Gomes DC, Schwedersky RP, Barbosa De-Melo LD, Da Silva Costa Souza BL, De Matos Guedes HL, Lopes UG, Rossi-Bergmann B. Peripheral expression of LACK-mRNA induced by intranasal vaccination with PCI-NEO-LACK defines the protection duration against murine visceral leishmaniasis. Parasitology. 2012;139(12):1562\u20139. doi: 10.1017\/S0031182012000868 .","journal-title":"Parasitology"},{"issue":"10","key":"1822_CR26","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1016\/j.vaccine.2009.12.055","volume":"28","author":"S Sakai","year":"2010","unstructured":"Sakai S, Takashima Y, Matsumoto Y, Reed SG, Hayashi Y, Matsumoto Y. Intranasal immunization with Leish-111f induces IFN-gamma production and protects mice from Leishmania major infection. Vaccine. 2010;28(10):2207\u201313. doi: 10.1016\/j.vaccine.2009.12.055 .","journal-title":"Vaccine"},{"issue":"14","key":"1822_CR27","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/j.vaccine.2006.05.093","volume":"25","author":"RO Pinheiro","year":"2007","unstructured":"Pinheiro RO, Pinto EF, de Matos Guedes HL, Filho OA, de Mattos KA, Saraiva EM, et al. Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan. Vaccine. 2007;25(14):2716\u201322.","journal-title":"Vaccine"},{"issue":"2","key":"1822_CR28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<424::AID-IMMU424>3.0.CO;2-U","volume":"28","author":"SJ McSorley","year":"1998","unstructured":"McSorley SJ, Rask C, Pichot R, Julia V, Czerkinsky C, Glaichenhaus N. Selective tolerization of Th1-like cells after nasal administration of a cholera toxoid-LACK conjugate. Eur J Immunol. 1998;28(2):424\u201332.","journal-title":"Eur J Immunol"},{"issue":"1","key":"1822_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003439","volume":"9","author":"L Silva-Couto da","year":"2015","unstructured":"da Silva-Couto L, Ribeiro-Rom\u00e3o RP, Saavedra AF, da Silva Costa Souza BL, Moreira OC, Gomes-Silva A, et al. Intranasal vaccination with leishmanial antigens protects golden hamsters (Mesocricetus auratus) against Leishmania (Viannia) braziliensis infection. PLoS Negl Trop Dis. 2015;9(1), e3439. doi: 10.1371\/journal.pntd.0003439 .","journal-title":"PLoS Negl Trop Dis"},{"issue":"14","key":"1822_CR30","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1017\/S0031182011001417","volume":"138","author":"DC Oliveira Gomes DE","year":"2011","unstructured":"DE Oliveira Gomes DC, DA Silva Costa Souza BL, DE Matos Guedes HL, Lopes UG, Rossi-Bergmann B. Intranasal immunization with LACK-DNA promotes protective immunity in hamsters challenged with Leishmania chagasi. Parasitology. 2011;138(14):1892\u20137. doi: 10.1017\/S0031182011001417 .","journal-title":"Parasitology"},{"key":"1822_CR31","doi-asserted-by":"crossref","first-page":"289597","DOI":"10.1155\/2011\/289597","volume":"2011","author":"AL Thompson","year":"2011","unstructured":"Thompson AL, Staats HJ. Cytokines: the future of intranasal vaccine adjuvants. Clin Dev Immunol. 2011;2011:289597.","journal-title":"Clin Dev Immunol."},{"issue":"1","key":"1822_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1586\/erv.12.140","volume":"12","author":"DT O\u2019Hagan","year":"2013","unstructured":"O\u2019Hagan DT, Ott GS, Nest GV, Rappuoli R, Giudice GD. The history of MF59(\u00ae) adjuvant: a phoenix that arose from the ashes. Expert Rev Vaccines. 2013;12(1):13\u201330. doi: 10.1586\/erv.12.140 . Review.","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"1822_CR33","first-page":"249","volume":"15","author":"CA Cuba-Cuba","year":"1981","unstructured":"Cuba-Cuba CA, Marsden PD, Barreto AC, Rocha R, Sampaio RR, Patzlaff L. Parasitologic and immunologic diagnosis of American (mucocutaneous) leishmaniasis. Bull Pan Am Healph Organ. 1981;15(3):249\u201359.","journal-title":"Bull Pan Am Healph Organ"},{"issue":"1089","key":"1822_CR34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1098\/rspb.1974.0085","volume":"187","author":"R Killick-Kendrick","year":"1974","unstructured":"Killick-Kendrick R, Molyneux DH, Ashford RW. Leishmania in phlebotomid sandflies. I. Modifications of the flagellum associated with attachment to the mid-gut and oesophageal valve of the sandfly. Proc R Soc Lond B Biol Sci. 1974;187(1089):409\u201319.","journal-title":"Proc R Soc Lond B Biol Sci"},{"issue":"33","key":"1822_CR35","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1016\/j.vaccine.2010.04.109","volume":"28","author":"HL Matos Guedes de","year":"2010","unstructured":"de Matos Guedes HL, Pinheiro RO, Chaves SP, De-Simone SG, Rossi-Bergmann B. Serine proteases of Leishmania amazonensis as immunomodulatory and disease-aggravating components of the crude LaAg vaccine. Vaccine. 2010;28(33):5491\u20136. doi: 10.1016\/j.vaccine.2010.04.109 .","journal-title":"Vaccine"},{"issue":"3","key":"1822_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.coi.2010.04.004","volume":"22","author":"ML Mbow","year":"2010","unstructured":"Mbow ML, De Gregorio E, Valiante NM, Rappuoli R. New adjuvants for human vaccines. Curr Opin Immunol. 2010;22(3):411\u20136. doi: 10.1016\/j.coi.2010.04.004 .","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"1822_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/ilar\/ilv009","volume":"56","author":"V Gerdts","year":"2015","unstructured":"Gerdts V, Wilson HL, Meurens F, van Drunen Littel-van den Hurk S, Wilson D, Walker S, et al. Large animal models for vaccine development and testing. ILAR J. 2015;56(1):53\u201362. doi: 10.1093\/ilar\/ilv009 .","journal-title":"ILAR J"},{"issue":"6","key":"1822_CR38","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1086\/382135","volume":"189","author":"MG Mendon\u00e7a","year":"2004","unstructured":"Mendon\u00e7a MG, de Brito ME, Rodrigues EH, Bandeira V, Jardim ML, Abath FG. Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: Is there a sterile cure? J Infect Dis. 2004;189(6):1018\u201323.","journal-title":"J Infect Dis"},{"key":"1822_CR39","doi-asserted-by":"crossref","unstructured":"Yarley V, Croft SL. Chapert 93.Animal models of cutaneous leishmaniasis. In: Zak SO, Merle A, editors. Handbook of Animals models of infection. London: Academic Press, p. 775-781","DOI":"10.1016\/B978-012775390-4\/50232-3"},{"issue":"Suppl","key":"1822_CR40","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1017\/S0031182000072243","volume":"98","author":"F Modabber","year":"1989","unstructured":"Modabber F. Experiences with vaccines against cutaneous leishmaniasis: of men and mice. Parasitology. 1989;98(Suppl):S49\u201360.","journal-title":"Parasitology."},{"key":"1822_CR41","doi-asserted-by":"publisher","first-page":"215964","DOI":"10.4061\/2011\/215964","volume":"2011","author":"M Podaliri Vulpiani","year":"2011","unstructured":"Podaliri Vulpiani M, Iannetti L, Paganico D, Iannino F, Ferri N. Methods of control of the Leishmania infantum dog reservoir: State of the art. Vet Med Int. 2011;2011:215964. doi: 10.4061\/2011\/215964 .","journal-title":"Vet Med Int."},{"issue":"5","key":"1822_CR42","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/embor.2012.32","volume":"13","author":"SL Russell","year":"2012","unstructured":"Russell SL, Gold MJ, Hartmann M, Willing BP, Thorson L, Wlodarska M, et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 2012;13(5):440\u20137. doi: 10.1038\/embor.2012.32 .","journal-title":"EMBO Rep"},{"issue":"3","key":"1822_CR43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S0031182000048186","volume":"76","author":"LD Hendricks","year":"1978","unstructured":"Hendricks LD, Wood DE, Hajduk ME. Haemoflagellates: commercially available liquid media for rapid cultivation. Parasitology. 1978;76(3):309\u201316.","journal-title":"Parasitology"},{"issue":"2","key":"1822_CR44","first-page":"206","volume":"71","author":"A Martiny","year":"1996","unstructured":"Martiny A, Vannier-Santos MA, Borges VM, Meyer-Fernandes JR, Assreuy J, Silva NL C e, de Souza W. Leishmania-induced tyrosine phosphorylation in the host macrophage and its implication to infection. Eur J Cell Biol. 1996;71(2):206\u201315.","journal-title":"Eur J Cell Biol"},{"issue":"4","key":"1822_CR45","first-page":"1059","volume":"18","author":"SM Cupolilo","year":"2003","unstructured":"Cupolilo SM, Souza CS, Abreu-Silva AL, Calabrese KS, da Costa SC G. Biological behavior of Leishmania (L.) amazonensis isolated from a human diffuse cutaneous leishmaniasis in inbred strains of mice. Histol Histopathol. 2003;18(4):1059\u201365.","journal-title":"Histol Histopathol"},{"issue":"7","key":"1822_CR46","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nm.3221","volume":"19","author":"DS Lima-Junior","year":"2013","unstructured":"Lima-Junior DS, Costa DL, Carregaro V, Cunha LD, Silva AL, Mineo TW, et al. Inflammasome-derived IL-1\u03b2 production induces nitric oxide-mediated resistance to Leishmania. Nat Med. 2013;19(7):909\u201315. doi: 10.1038\/nm.3221 .","journal-title":"Nat Med"},{"issue":"6","key":"1822_CR47","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1590\/S0074-02762010000600002","volume":"105","author":"DF C\u00f4rtes","year":"2010","unstructured":"C\u00f4rtes DF, Carneiro MB, Santos LM, Souza TC, Maioli TU, Duz AL, et al. Low and high-dose intradermal infection with Leishmania major and Leishmania amazonensis in C57BL\/6 mice. Mem Inst Osw Cruz. 2010;105(6):736\u201345.","journal-title":"Mem Inst Osw Cruz"},{"issue":"4","key":"1822_CR48","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4269\/ajtmh.2002.66.338","volume":"66","author":"J Ji","year":"2002","unstructured":"Ji J, Sun J, Qi H, Soong L. Analysis of T helper cell responses during infection with Leishmania amazonensis. Am J Trop Med Hyg. 2002;66(4):338\u201345.","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"1822_CR49","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.4049\/jimmunol.167.8.4534","volume":"167","author":"H Qi","year":"2001","unstructured":"Qi H, Popov V, Soong L. Leishmania amazonensis-dendritic cell interactions in vitro and the priming of parasite-specific CD4(+) T cells in vivo. J Immunol. 2001;167(8):4534\u201342.","journal-title":"J Immunol"},{"issue":"4","key":"1822_CR50","first-page":"947","volume":"147","author":"A Barral","year":"1995","unstructured":"Barral A, Teixeira M, Reis P, Vinhas V, Costa J, Lessa H, et al. Transforming growth factor-beta in human cutaneous leishmaniasis. Am J Pathol. 1995;147(4):947\u201354.","journal-title":"Am J Pathol"},{"issue":"9","key":"1822_CR51","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1084\/jem.20142101","volume":"212","author":"ND Glennie","year":"2015","unstructured":"Glennie ND, Yeramilli VA, Beiting DP, Volk SW, Weaver CT, Scott P. Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection. J Exp Med. 2015;212(9):1405\u201314. doi: 10.1084\/jem.20142101 .","journal-title":"J Exp Med"},{"key":"1822_CR52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000425059","volume":"63","author":"P Scott","year":"1996","unstructured":"Scott P. Th cell development and regulation in experimental cutaneous leishmaniasis. Chem Immunol. 1996;63:98\u2013114.","journal-title":"Chem Immunol."},{"key":"1822_CR53","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.exppara.2015.07.005","volume":"157","author":"HW Murray","year":"2015","unstructured":"Murray HW, Mitchell-Flack M, Taylor GA, Ma X. IFN-\u03b3-induced macrophage antileishmanial mechanisms in mice: A role for immunity-related GTPases, Irgm1 and Irgm3, in Leishmania donovani infection in the liver. Exp Parasitol. 2015;157:103\u20139. doi: 10.1016\/j.exppara.2015.07.005 .","journal-title":"Exp Parasitol."},{"issue":"2","key":"1822_CR54","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1128\/IAI.72.2.988-995.2004","volume":"72","author":"H Qi","year":"2004","unstructured":"Qi H, Ji J, Wanasen N, Soong L. Enhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis. Infect Immun. 2004;72(2):988\u201395.","journal-title":"Infect Immun"},{"issue":"1","key":"1822_CR55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/S0074-02762007000100013","volume":"102","author":"RO Pinheiro","year":"2007","unstructured":"Pinheiro RO, Rossi-Bergmann B. Interferon-gamma is required for the late but not early control of Leishmania amazonensis infection in C57Bl\/6 mice. Mem Inst Osw Cruz. 2007;102(1):79\u201382.","journal-title":"Mem Inst Osw Cruz"},{"issue":"3","key":"1822_CR56","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2014.4","volume":"3","author":"R Kumar","year":"2014","unstructured":"Kumar R, Engwerda C. Vaccines to prevent leishmaniasis. Clin Transl Immunology. 2014;3(3), e13.","journal-title":"Clin Transl Immunology"},{"key":"1822_CR57","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s13071-016-1777-x","volume":"9","author":"SC Mendon\u00e7a","year":"2016","unstructured":"Mendon\u00e7a SC. Differences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery. Parasit Vectors. 2016;9:492.","journal-title":"Parasit Vectors."},{"issue":"1","key":"1822_CR58","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13071-016-1553-y","volume":"9","author":"S Srivastava","year":"2016","unstructured":"Srivastava S, Shankar P, Mishra J, Singh S. Possibilities and challenges for developing a successful vaccine for leishmaniasis. Parasit Vectors. 2016;9(1):277.","journal-title":"Parasit Vectors"},{"issue":"11","key":"1822_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079194","volume":"8","author":"PH Goff","year":"2013","unstructured":"Goff PH, Eggink D, Seibert CW, Hai R, Mart\u00ednez-Gil L, Krammer F, Palese P. Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies. PLoS One. 2013;8(11), e79194. doi: 10.1371\/journal.pone.0079194 .","journal-title":"PLoS One"},{"issue":"20","key":"1822_CR60","doi-asserted-by":"publisher","first-page":"11107","DOI":"10.1128\/JVI.01554-13","volume":"87","author":"C Cayatte","year":"2013","unstructured":"Cayatte C, Schneider-Ohrum K, Wang Z, Irrinki A, Nguyen N, Lu J, et al. Cytomegalovirus vaccine strain towne-derived dense bodies induce broad cellular immune responses and neutralizing antibodies that prevent infection of fibroblasts and epithelial cells. J Virol. 2013;87(20):11107\u201320. doi: 10.1128\/JVI.01554-13 .","journal-title":"J Virol"},{"issue":"33","key":"1822_CR61","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1016\/j.vaccine.2013.05.007","volume":"31","author":"S Calabro","year":"2013","unstructured":"Calabro S, Tritto E, Pezzotti A, Taccone M, Muzzi A, Bertholet S, et al. The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect. Vaccine. 2013;31(33):3363\u20139. doi: 10.1016\/j.vaccine.2013.05.007 .","journal-title":"Vaccine"},{"key":"1822_CR62","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4615-1823-5_10","volume":"6","author":"G Ott","year":"1995","unstructured":"Ott G, Barchfeld GL, Chernoff D, Radhakrishnan R, van Hoogevest P, Van Nest G. MF59. Design and evaluation of a safe and potent adjuvant for human vaccines. Pharm Biotechnol. 1995;6:277\u201396.","journal-title":"Pharm Biotechnol"},{"issue":"4","key":"1822_CR63","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00436-007-0630-8","volume":"101","author":"HL Matos Guedes de","year":"2007","unstructured":"de Matos Guedes HL, Duarte Carneiro MP, de Oliveira Gomes DC, Rossi-Bergmann B, Giovanni D-SS. Oligopeptidase B from Leishmania amazonensis: molecular cloning, gene expression analysis and molecular model. Parasitol Res. 2007;101(4):865\u201375.","journal-title":"Parasitol Res"},{"key":"1822_CR64","first-page":"197","volume":"53","author":"HL Matos Guedes de","year":"2008","unstructured":"de Matos Guedes HL, de Carvalho RSN, de Oliveira Gomes DC, Rossi-Bergman B, De Simone SG. Oligopeptidase B-2 from Leishmania amazonensis with an unusual C-terminal extension. Acta Parasitolog. 2008;53:197.","journal-title":"Acta Parasitolog"},{"key":"1822_CR65","doi-asserted-by":"crossref","unstructured":"Chaves SP, de Oliveira Gomes DC, De Simone SG, Rossi-Bergman B, de Matos Guedes HL. Serine proteases and vaccines against Leishmaniasis: a dual role vaccines vaccin. 2015;6:1. http:\/\/dx.doi.org\/10.4172\/2157-7560.1000264 , http:\/\/www.omicsonline.org\/open-access\/serine-proteases-and-vaccines-against-leishmaniasis-a-dual-role-2157-7560.1000264.pdf .","DOI":"10.4172\/2157-7560.1000264"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-016-1822-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T10:28:15Z","timestamp":1692527295000},"score":1,"resource":{"primary":{"URL":"http:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-016-1822-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,6]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1822"],"URL":"https:\/\/doi.org\/10.1186\/s13071-016-1822-9","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,6]]},"article-number":"534"}}